Loading organizations...
Loading organizations...
Immune cell drug developer focused on cancer therapies.
Neukio Biotherapeutics has raised $90.0M across 2 funding rounds.
Neukio Biotherapeutics has raised $90.0M in total across 2 funding rounds.
Neukio Biotherapeutics has raised $90.0M in total across 2 funding rounds.
Neukio Biotherapeutics's investors include IDG Capital, Lilly Asia Ventures, Sherpa Healthcare Partners, Surplus Capital, Yi Shi, Haoyue Hu, Darren Cai.
Neukio Biotherapeutics has raised $90.0M across 2 funding rounds. Most recently, it raised $50.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 4, 2022 | $50.0M Series A | IDG Capital, Lilly Asia Ventures, Sherpa Healthcare Partners, Surplus Capital | |
| Jul 30, 2021 | $40.0M Other Equity | Yi Shi | Haoyue Hu, Darren Cai |